Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch
Apollo Hospitals faces a pivotal Q1 FY27 as it balances a seasonally softer quarter for elective procedures against strong structural demand for complex specialties like oncology and cardiac care. Investors will be closely watching for the promised breakeven of the Apollo 24/7 digital business and the ramp-up status of its new hospital capacity.
| Results date | August 12, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Previous quarter revenue | Rs. 6,605.5 Cr |
| Previous quarter PAT | Rs. 529.2 Cr |
| Previous quarter EBITDA margin | 15.3% |
| Net debt (latest quarter) | Rs. 865.9 Cr |
| Market cap | Rs. 131,493.56 Cr |
| CMP | Rs. 8980.5 |
Apollo Hospitals Enterprise Limited Q1 Results Date and Time
The board meeting is scheduled for August 12, 2026, to approve the unaudited financial results for the quarter ended June 30, 2026.
What to expect from Apollo Hospitals Enterprise Limited's Q1 FY27 results
Apollo Hospitals enters Q1 FY27 with a strong structural tailwind, as management targets 12-14% organic revenue growth for established hospitals following a 13-14% growth rate in Q4 FY26. The company is navigating a seasonal elective lull, but management has highlighted robust demand for complex procedures and a 28% month-on-month rise in dengue cases by May 2026 as potential offsets to hospital occupancy.
A critical focus for the quarter is the digital business, where management has guided toward ex-ESOP breakeven for Apollo 24/7 in Q1 FY27, following a cash loss of Rs. 16.4 Cr in Q4 FY26. Furthermore, the company is managing a new hospital expansion pipeline, with 185 beds already operational out of 1,400 planned, and is tracking against a Rs. 150 Cr EBITDA loss guidance for these units in FY27.
Finally, the upcoming earnings call will likely address the sustainability of the 25.5% EBITDA margin in established hospitals and the progress of the Apollo Healthtech demerger, which is expected to conclude by Q4 FY27.
Key Things To Watch
Performance vs Guidance Tracking: Tracking key management targets for FY27.
- Apollo 24/7 ex-ESOP breakeven — Q1 FY27 target — pivotal test this quarter
- Healthcare Services established EBITDA margin — 25.5% sustainable — tracking progress
- New hospital EBITDA loss — Rs. 150 Cr for FY27 — tracking quarterly run-rate
Digital and Pharmacy Trajectory: Monitoring the path toward HealthCo profitability.
- Digital cash loss trend vs Rs. 16.4 Cr in Q4 FY26
- Offline pharmacy margin sustainability vs 7.7% in Q4 FY26
- HealthCo annualized revenue run-rate progress toward Rs. 25,000 Cr target
Hospital Operational Focus: Updates on capacity and patient metrics.
- Occupancy levels in Q1 vs 68% in Q4 FY26
- New bed commissioning status for Bangalore Sarjapur and Gurugram units
- ALOS and ARPOB trends in the context of robotic surgery adoption
Strategic and Financial Updates: Key corporate actions and balance sheet health.
- Demerger and listing timeline for Apollo Healthtech
- Completion status of AHLL divestment to Cloudnine
Ask about this
Ask Cofacto a question about this company. Answers cite filings and company data.
Frequently Asked Questions
Is Apollo Hospitals' revenue growing?
Consolidated revenue grew 16% YoY to Rs. 25,229 Cr in FY26, with Q4 FY26 revenue reaching Rs. 6,605 Cr. Management expects organic growth for established hospitals to continue in the 12-14% range for FY27.
When does Apollo expect its digital business to break even?
Management has guided for Apollo 24/7 to reach EBITDA breakeven (excluding ESOP) in Q1 FY27. The digital cash loss narrowed to Rs. 16.4 Cr in Q4 FY26, marking progress toward this goal.
What is the status of the new hospital expansion?
As of Q4 FY26, 185 beds were operational out of a 1,400-bed pipeline. The company targets having 500-600 beds operational by mid-FY27, with new units expected to reach breakeven by FY28.
Related
- Apollo Hospitals Q1 FY27 Results Analysis: Revenue Surges 21%, EBITDA Margin Expands 90 bps (APOLLOHOSP)Q1 FY2026-2027 Results Analysis
- Apollo Hospitals Q1 FY27 Earnings Call: Guides 20% Hospital Revenue Growth, Digital Cash Loss Nears Break-Even (APOLLOHOSP)Q1 FY2026-2027 Earnings Call
- APOLLOHOSP Q4 FY26 Results Analysis: PAT Surges 33%, Digital Health Turns ProfitableQ4 FY2025-2026 Analysis